Antibody-urease conjugates
US10316311B2 · kind B2 · utility
0Cited by
4References
18Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 3, 2014 |
| Grant date | Jun 11, 2019 |
| Priority date | — |
| Expiry date | Apr 22, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y305/01005
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure provides antibody-urease conjugates having therapeutic and diagnostic utility. More specifically, the disclosure relates to diagnostic and/or therapeutic conjugates that are prepared by conjugating one or more whole antibodies to urease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.